<DOC>
	<DOCNO>NCT01876563</DOCNO>
	<brief_summary>The aim study comparision effect vitamin D placebo supplementation 2 month serum level thioredoxin , TBP-2 thioredoxin reductase activity patient type 2 diabetes</brief_summary>
	<brief_title>Effect Vitamin D Serum Thioredoxin , TBP-2 , Thioredoxin Reductase , Gene Expression TBP-2 Patients With Type II Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>literate , willingness participation , diabetic patient 30 60 year old , body mass index range 18.5 35 , avoidance dietary supplement , vitamin herbal product least 3 month throughout intervention people use vitamin D supplement last 3 month , chronic renal disease , GI disease , Hepatobilliary diseases , hematological disorder , hypo hyperthyroidism , treatment orlistat sibutramine weight loss , pregnancy lactation , treatment insulin Thiazolidinediones , Smokers</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>thioredoxin</keyword>
	<keyword>TBP-2</keyword>
	<keyword>thioredoxin reductase</keyword>
	<keyword>vitamin D</keyword>
	<keyword>DIABETES</keyword>
</DOC>